We are live on ! Find out more
KYTX icon

Kyverna Therapeutics
KYTX

94 hedge funds and large institutions have $138M invested in Kyverna Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

14% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 22

7% more funds holding

Funds holding: 88 → 94 (+6)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8.85% less ownership

Funds ownership: 74.08% → 65.22% (-8.9%)

42% less capital invested

Capital invested by funds: $240M → $138M (-$101M)

90% less call options, than puts

Call options by funds: $7K | Put options by funds: $67K

Holders
94
Holders Change
+6
Holders Change %
+6.82%
% of All Funds
1.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
27
Increased
25
Reduced
22
Closed
21
Calls
$7K
Puts
$67K
Net Calls
-$60K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.55M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.51M
3
MPM
MBB Public Markets
Illinois
+$1.57M
4
IHAM
Integral Health Asset Management
New York
+$1.54M
5
Franklin Resources
Franklin Resources
California
+$878K

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$13.9M
2
DM
Deerfield Management
New York
-$8.2M
3
CC
Casdin Capital
New York
-$4.31M
4
GPP
Great Point Partners
Connecticut
-$3.74M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
51
Marshall Wace
United Kingdom
$158K +$168K +21,823 +210%
Federated Hermes
52
Federated Hermes
Pennsylvania
$156K +$123K +16,000 +100%
AllianceBernstein
53
AllianceBernstein
Tennessee
$147K +$33.2K +4,300 +17%
OQS
54
Occudo Quantitative Strategies
Florida
$135K +$213K +27,580 New
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$133K +$200K +25,997 +2,166%
Skandinaviska Enskilda Banken (SEB)
56
Skandinaviska Enskilda Banken (SEB)
Sweden
$128K – – –
DCM
57
Discovery Capital Management
Connecticut
$122K – – –
CC
58
Caxton Corporation
New Jersey
$112K – – –
SAM
59
Sectoral Asset Management
Quebec, Canada
$112K +$123K +15,900 +227%
N
60
Nuveen
North Carolina
$112K – – –
PCM
61
Prelude Capital Management
New York
$105K +$165K +21,395 New
Jacobs Levy Equity Management
62
Jacobs Levy Equity Management
New Jersey
$97.2K +$153K +19,869 New
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$96.7K -$1.85K -240 -1%
Two Sigma Advisers
64
Two Sigma Advisers
New York
$82.6K +$130K +16,900 New
Bank of America
65
Bank of America
North Carolina
$75.2K -$75.6K -9,811 -39%
Citigroup
66
Citigroup
New York
$66K +$64.1K +8,318 +161%
TRCT
67
Tower Research Capital (TRC)
New York
$62.8K +$99.1K +12,849 New
Creative Planning
68
Creative Planning
Kansas
$53.9K +$85K +11,028 New
TC
69
TwinBeech Capital
New York
$49.8K +$78.5K +10,179 New
Mirae Asset Global ETFs Holdings
70
Mirae Asset Global ETFs Holdings
Hong Kong
$45.5K +$71.7K +9,298 New
CF
71
Corebridge Financial
Texas
$44K -$432 -56 -0.6%
UBS Group
72
UBS Group
Switzerland
$40.1K -$11.2K -1,448 -15%
Fidelity Investments
73
Fidelity Investments
Massachusetts
$32.7K +$51.6K +6,692 New
VEA
74
Virtus ETF Advisers
New York
$31.2K +$863 +112 +2%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$22K -$70.2K -9,100 -67%
1 2
3
4 5

KYTX Hedge Fund Activity: Q3 2024 in Review

94 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Kyverna Therapeutics (KYTX) for Q3 2024, worth a combined $138M — down 42% from $240M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new KYTX positions and 21 closed out — a net gain of 6 holders — while 25 added to existing stakes and 22 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.55M. The largest seller was RTW Investments, exiting entirely with an estimated $13.9M sold.

  • 94 institutional investors held Kyverna Therapeutics (KYTX) as of Q3 2024, up from 88 in Q2 2024.
  • Funds reported $138M of Kyverna Therapeutics stock for Q3 2024, down 42% quarter-over-quarter.
  • 27 funds opened new Kyverna Therapeutics positions in Q3 2024 and 21 closed out, a net change of +6 holders.
  • The largest Kyverna Therapeutics buyer in Q3 2024 was Millennium Management, an estimated $2.55M added.
  • The largest Kyverna Therapeutics seller in Q3 2024 was RTW Investments, an estimated $13.9M sold.

Based on aggregated 13F filings for Q3 2024.